A team of researchers from @UNLComputing and Princeton "aims to discover how natural structures in bacterial gene networks could be leveraged for AI applications": https://t.co/JlynHhqqjn
Living with #UlcerativeColitis can mean symptoms and challenges that often go unseen. In our Voices of Innovation Series, Sunny Anderson shares her UC journey and why awareness and patient support matter.
🔗 Watch now: https://t.co/7HlRPPBa3C
NIH's Dr. Susan Gregurick highlights AIM-AHEAD's breakthroughs in AI/ML for biomedical research! Learn how this program is advancing data science and healthcare innovation: https://t.co/1nmaeZNeaq
On #WorldElephantDay, let us take a moment to thank the veterinary professionals who care for these magnificent mammals. Plus, be sure to check out @AVMAJAVMA's study on recent cases of EEHV2 infection in African elephants at North American institutions: https://t.co/DVGCx9s64c
Backed by funding from the @NIH, a Johns Hopkins clinical trial helped pave the way for @US_FDA approval of Xolair as a treatment for food allergies. In just over a year, about 50,000 people have started using it, making it the fastest-adopted drug in its class. https://t.co/zKey3Gr9xB #ResearchSavesLives
NIH scientists made many impressive discoveries last year that could help lead to ways to reverse blindness-inducing cataracts, diagnose fungal infections, and more. Learn about these & other recent milestones: https://t.co/PyPOkodUyJ
Tiny genetic alterations could help the bird flu virus enter cells in the upper respiratory tract, the C.D.C. said. But there is no sign that mutations are widespread in nature. https://t.co/q6292Nhz7p
Congratulations to NIDDK’s Dr. Ifechukwude Ebenuwa who was selected as a 2024 @NIH Distinguished Scholar alongside 14 colleagues from @NIAIDNews, @NatEyeInstitute, @NIHAging, @NCIResearchCtr, @NIEHS, @NIHClinicalCntr, @NICHD_NIH, and @NIH_NINDS! https://t.co/KxAzdet0ig
Check out the latest FDA Roundup, our at-a-glance summary of agency updates: https://t.co/IdzLnWMRqa
We invite the public to register for the public meeting on the Development of an Enhanced Systematic Process for the FDA’s Post-Market Assessment of Chemicals in Food, which will be held on September 25, 2024, from 12:30-4:30 p.m. ET. https://t.co/S5Z7SOMsGN
We released a set of documents regarding the transition phase after the agency’s longstanding Memorandum of Understanding with the Association of American Feed Control Officials (AAFCO) expires on October 1, 2024. https://t.co/Vw8nssXHPN
We released our updated 2024 Language Access Plan, taking another key step toward addressing language barriers that impact health equity and strengthening language access to health information and services for the public, including people with Limited English Proficiency and people with disabilities. https://t.co/lnpK7DB4Fw
Yesterday, we granted an emergency use authorization to Octapharma Pharmazeutika Produktionsges.m.b.H. for emergency use of octaplasLG Powder (blood group types A and AB) for U.S. military forces for the treatment of hemorrhage or coagulopathy during an emergency involving agents of military combat (e.g., firearms, projectiles, and explosive devices) when plasma is not available for use or when the use of plasma is not practical. https://t.co/Sq3nobvGSe
Wednesday, we updated the list of Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices. https://t.co/gTa8mMwELA
Lastly, we published a blog titled FDA India Office Addresses Herbal and Ayurvedic Products. https://t.co/HQDflwwK3H
🤔 What is it? #Hyperthyroidism, also called overactive thyroid, is when the thyroid gland makes more thyroid hormones than your body needs. With too much #thyroid hormone, many of your body’s functions speed up. https://t.co/X71O1pUa1N
#NIDDK#WorldThyroidDay
On International Women's Day, we celebrate all of the women who play a part in nurturing the world and humankind by advancing animal care. #ZoetisProud#IWD2023#animalhealth#thankyou